A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Johnson, Miriam J ^a   Kanaan, Mona ^b   Richardson, Gerry ^b   Nabb, Samantha ^c   Torgerson, David ^b   English, Anne ^d,e   Barton, Rachael ^f   Booth, Sara ^g,h  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

^d Dove House Hospice   (United Kingdom)

^e Clinical Psychology Service for Older People   (United Kingdom)

^f CASTLE HILL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Breathing training; Breathlessness; Cancer; Dyspnoea; Neoplasm

Indexed keywords

AGED; ANXIETY; ARTICLE; BREATHING EXERCISE; CONTROLLED STUDY; COPING BEHAVIOR; COST EFFECTIVENESS ANALYSIS; DISTRESS SYNDROME; DYSPNEA; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; LUNG CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON SMALL CELL LUNG CANCER; PARALLEL DESIGN; PLEURA MESOTHELIOMA; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SMALL CELL LUNG CANCER; THERAPY EFFECT; TREATMENT OUTCOME; UNITED KINGDOM; ADULT; CLINICAL TRIAL; COMPLICATION; COST BENEFIT ANALYSIS; ECONOMICS; LUNG NEOPLASMS; MIDDLE AGED; PALLIATIVE THERAPY; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREATHING EXERCISES; COST-BENEFIT ANALYSIS; DYSPNEA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; QUALITY-ADJUSTED LIFE YEARS;

EID: 84940878294     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0453-x     Document Type: Article

References (39)

1. th August 2015
2. Muers MF, Round CE. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax. 1993;48:339-43.
3. Edmonds P, Higginson I, Altmann D, Sen-Gupta G, McDonnell M. Is the presence of dyspnea a risk factor for morbidity in cancer patients? J Pain Symptom Manage. 2000;19:15-22.
4. Saracino A, Weiland TJ, Jolly B, Dent AW. Verbal dyspnoea score predicts emergency department departure status in patients with shortness of breath. Emerg Med Australas. 2010;22:21-9.
5. Zhao I, Yates P. Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med. 2008;22:693-701.
6. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care. 2006;4:287-93.
7. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999;318:901-4.
8. Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med. 1996;10:299-305.
9. Yates P, Hardy J, Kwun F, Brunelli V, Zhao I, Clavarino I. A randomised controlled trial of a nonpharmacological intervention for dyspnoea. [Abstract] Clinical Oncological Society of Australia (COSA) 38th Annual Scientific Meeting, Perth, Western Australia. Asia-Pacific Journal of Clinical Oncology. Blackwell Publishing Asia, Australia 2011; 7:82
10. Farquhar MC, Prevost A, McCrone P, Brafman-Price B, Bentley A, Higginson IJ, et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed-method randomised controlled trial. BMC Med. 2014;12:194.
11. Higginson IJ, Bausewein C, Reilly C, Wei G, Gysels M, Dzingas M, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2:979-87.
12. NICE. Guidance for the Diagnosis and Treatment of Lung Cancer. Methods, evidence & guidance. London: National Collaborating Centre for Acute Care; 2005.
13. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13-64.
14. Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011;7, CD001800.
15. Granger CL, McDonald CF, Berney S, Chao C, Denehy L. Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer. 2011;72:139-53.
16. Johnson M, Moore S. Research into practice: the reality of implementing a non-pharmacological breathlessness intervention into clinical practice. Eur J Oncol Nurs. 2003;7:33-8.
17. Booth S, Bausewein C, Higginson I, Moosavi SH. Pharmacological treatment of refractory breathlessness. Expert Rev Respir Med. 2009;3:21-36.
18. Barton R, English A, Nabb S, Rigby AS, Johnson MJ. A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer. 2010;70:313-9.
19. Wilcock A, Crosby V, Clarke D, Tattersfield A. Repeatability of breathlessness measurements in cancer patients. Thorax. 1999;54:375.
20. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998;7:200-4.
21. Schunemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J. 2005;25:31-40.
22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.
23. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CC, editor. Evaluation of chemotherapeutic agents in cancer. New York: Columbia University Press; 1949. p. 191-205.
24. Kind P. The EuroQoL instrument: an index of health-related quality of life. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven; 1996.
25. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4:92-100.
26. John OP. Big five trait taxonomy. In: Pervin LA, John OP, editors. Handbook of Theory and Research. 2nd ed. New York, NY: The Guilford Press; 2001.
27. Kahan BC, Morris TP. Adjusting for multiple prognostic factors in the analysis of randomised trials. BMC Med Res Methodol. 2013;13:99.
28. Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC. Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage. 2013;46:957-63.
29. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol. 2009;167:53-60.
30. Parshall MB, Meek PM, Sklar D, Alcock J, Bittner P. Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study. BMC Emerg Med. 2012;12:6.
31. von Leupoldt A, Ambruzsova R, Nordmeyer S, Jeske N, Dahme B. Sensory and affective aspects of dyspnea contribute differentially to the Borg scale's measurement of dyspnea. Respiration. 2006;73:762-8.
32. Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR, Abernethy AP. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage. 2010;39:680-90.
33. Li J, Girgis A. Supportive care needs: are patients with lung cancer a neglected population? Psychooncology. 2006;15:509-16.
34. Rueda JR, Sola I, Pascual A, Subirana CM. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev. 2011;9, CD004282.
35. Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, et al. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med. 2008;168:1783-90.
36. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733-42.
37. Kutikova L, Bowman L, Chang S, Long SR, Obasaju C, Crown WH. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Lung Cancer. 2005;50:143-54.
38. de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121:1092-8.
39. Blagbrough M, Coulthard M. The Calming Hand. Oxford Textbook of Palliative Medicine. 4th ed. Oxford: Oxford University Press; 2010.